Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice
AR Genazzani, P Monteleone… - Human reproduction …, 2021 - academic.oup.com
BACKGROUND Menopausal symptoms can be very distressing and considerably affect a
woman's personal and social life. It is becoming more and more evident that leaving …
woman's personal and social life. It is becoming more and more evident that leaving …
Performance and reporting of clinical breast examination: a review of the literature
S McDonald, D Saslow… - CA: a cancer journal for …, 2004 - Wiley Online Library
Clinical breast examination (CBE) seeks to detect breast abnormalities or evaluate patient
reports of symptoms to find palpable breast cancers at an earlier stage of progression, when …
reports of symptoms to find palpable breast cancers at an earlier stage of progression, when …
Breast cancer risk in postmenopausal women using estradiol–progestogen therapy
H Lyytinen, E Pukkala, O Ylikorkala - Obstetrics & Gynecology, 2009 - journals.lww.com
OBJECTIVE: To estimate the risk for breast cancer in Finnish women using postmenopausal
estradiol (E2)–progestogen therapy. METHODS: All Finnish women over 50 years using E2 …
estradiol (E2)–progestogen therapy. METHODS: All Finnish women over 50 years using E2 …
Breast cancer risk in postmenopausal women using estrogen-only therapy
H Lyytinen, E Pukkala, O Ylikorkala - Obstetrics & Gynecology, 2006 - journals.lww.com
OBJECTIVE: To evaluate whether the risk of estrogen-only therapy on breast cancer varies
by dose, constituent, and route of administration. METHODS: All Finnish women older than …
by dose, constituent, and route of administration. METHODS: All Finnish women older than …
[HTML][HTML] Results of R0 resection for colorectal liver metastases associated with extrahepatic disease
Background: Extrahepatic malignant disease has always been considered an absolute
contraindication to hepatectomy for colorectal liver metastases. This study reports the long …
contraindication to hepatectomy for colorectal liver metastases. This study reports the long …
Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population
K Kerlikowske, DL Miglioretti… - Journal of clinical …, 2003 - ascopubs.org
Purpose: We determined the risk of breast cancer and tumor characteristics among current
postmenopausal hormone therapy users compared with nonusers, by duration of use …
postmenopausal hormone therapy users compared with nonusers, by duration of use …
[HTML][HTML] Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk
L Hilakivi-Clarke, S De Assis, A Warri - Journal of mammary gland biology …, 2013 - Springer
Women are using estrogens for many purposes, such as to prevent pregnancy or
miscarriage, or to treat menopausal symptoms. Estrogens also have been used to treat …
miscarriage, or to treat menopausal symptoms. Estrogens also have been used to treat …
Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies
Previous studies on the association between hormone replacement therapy (HRT) and
breast cancer survival have yielded mixed results. We aimed to perform a meta-analysis to …
breast cancer survival have yielded mixed results. We aimed to perform a meta-analysis to …
[HTML][HTML] A critique of the Women's Health Initiative hormone therapy study
EL Klaiber, W Vogel, S Rako - Fertility and sterility, 2005 - Elsevier
OBJECTIVE: This review critiques The Women's Health Initiative (WHI) study, focusing on
aspects of the study design contributing to the adverse events resulting in the study's …
aspects of the study design contributing to the adverse events resulting in the study's …
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study
Background Postmenopausal hormone-replacement therapy (HRT) increases breast-cancer
risk. The influence of HRT on the biology of the primary tumor, however, is not well …
risk. The influence of HRT on the biology of the primary tumor, however, is not well …